Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Almitrine bismesylate.

P D Smith, V P Gotz, G G Ryerson

Drug Intelligence & Clinical Pharmacy

|May 1, 1987

Summary

This summary is machine-generated.

Almitrine bismesylate, a novel respiratory stimulant, boosts breathing by activating carotid body chemoreceptors. This investigational drug improves oxygen levels in COPD patients and may help nocturnal hypoxemia.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Effects of Racism on Oral Health in the United States.

Community dental health·2021

Same author

Ongoing design concerns of portable oxygen cylinders.

Anaesthesia and intensive care·2018

Same author

Helicobacter pylori infection is associated with an altered gastric microbiota in children.

Mucosal immunology·2017

Same author

Chyle leak following right axillary lymph node dissection: A case report and review of current literature.

International journal of surgery case reports·2016

Same author

Human gastric epithelial cells contribute to gastric immune regulation by providing retinoic acid to dendritic cells.

Mucosal immunology·2014

Same author

Bilateral spontaneous, simultaneous lower extremity hematomas in a patient on dalteparin.

International journal of surgery case reports·2013

Same journal

Profile of prescription medication in a pediatric population.

Drug intelligence & clinical pharmacy·1988

Same journal

SI units in drug therapeutics.

Drug intelligence & clinical pharmacy·1988

Same journal

Physicians' review of significant interventions by clinical pharmacists in inpatient care.

Drug intelligence & clinical pharmacy·1988

Same journal

Possible interaction of ranitidine with phenytoin.

Drug intelligence & clinical pharmacy·1988

Same journal

Famotidine-associated mental confusion in elderly patients.

Drug intelligence & clinical pharmacy·1988

Same journal

Intravenous self-administration of elemental mercury: efficacy of dimercaprol therapy.

Drug intelligence & clinical pharmacy·1988

See all related articles

Area of Science:

Pharmacology
Respiratory Medicine
Nephrology

Background:

Almitrine bismesylate is a unique respiratory stimulant.
It acts as an agonist of peripheral chemoreceptors on carotid bodies.
Offers advantages over traditional central-acting stimulants, including oral activity and prolonged effects.

Purpose of the Study:

To evaluate the efficacy of almitrine bismesylate in enhancing respiration.
To assess its impact on arterial blood gases in patients with chronic obstructive pulmonary disease (COPD).
To investigate its potential role in treating nocturnal oxygen desaturation.

Main Methods:

Administration of almitrine bismesylate (acute and chronic).
Measurement of arterial oxygen and carbon dioxide tension at rest and during exercise.

Related Experiment Videos

Assessment of ventilation and ventilation/perfusion matching.

Evaluation of sleep quality and nocturnal oxygen saturation.

Main Results:

Increased arterial oxygen tension and decreased carbon dioxide tension in COPD patients.
Improved ventilation and ventilation/perfusion matching.
Reduced frequency and severity of nocturnal hypoxemia without sleep impairment.

Conclusions:

Almitrine bismesylate effectively enhances respiration and improves gas exchange in COPD.
It demonstrates potential for treating nocturnal oxygen desaturation.
Further research is needed to fully define its therapeutic role in hypoxemia.